Molecular Pathways: Maintaining MAPK Inhibitor Sensitivity by Targeting Nonmutational Tolerance.
about
An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition.Overcoming resistance to BRAF inhibitors.Enhanced response of melanoma cells to MEK inhibitors following unbiased IGF-1R down-regulation.BRAF inhibition upregulates a variety of receptor tyrosine kinases and their downstream effector Gab2 in colorectal cancer cell lines.Cell death-based treatments of melanoma:conventional treatments and new therapeutic strategies.
P2860
Molecular Pathways: Maintaining MAPK Inhibitor Sensitivity by Targeting Nonmutational Tolerance.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Molecular Pathways: Maintainin ...... eting Nonmutational Tolerance.
@en
Molecular Pathways: Maintainin ...... eting Nonmutational Tolerance.
@nl
type
label
Molecular Pathways: Maintainin ...... eting Nonmutational Tolerance.
@en
Molecular Pathways: Maintainin ...... eting Nonmutational Tolerance.
@nl
prefLabel
Molecular Pathways: Maintainin ...... eting Nonmutational Tolerance.
@en
Molecular Pathways: Maintainin ...... eting Nonmutational Tolerance.
@nl
P2860
P1476
Molecular Pathways: Maintainin ...... geting Nonmutational Tolerance
@en
P2093
Claudia Wellbrock
Michael P Smith
P2860
P304
P356
10.1158/1078-0432.CCR-16-0954
P407
P577
2016-10-19T00:00:00Z